Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events

Technology appraisal guidance
Reference number: TA210
Published: 15 December 2010

TA210 Vascular disease - clopidogrel and dipyridamole: Appendix B proposal paper presented to the Institute's Guidance Executive

TA210 Vascular disease - clopidogrel and dipyridamole: Appendix B proposal paper presented to the Institute's Guidance Executive

TA210 Vascular disease - clopidogrel and dipyridamole: Appendix B proposal paper presented to the Institute's Guidance Executive
29 July 2013
(662.08 Kb 12 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 26 July 2013